Portfolio company
Asgard Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops gene therapies that reprogramme cancer cells into immune cells for patients with various types of tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Abalos Therapeutics
This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.
Captain T Cell
The company develops cell therapies for cancer patients to treat solid tumours.
DualTPharma
This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.
T-CURX
This biotech company develops non-viral CAR-T cell therapies to treat patients with leukaemia, lymphoma and solid tumours.
OverT
This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Kindling Bio
This company develops a gene therapy platform that engineers tumour cells to display markers for the immune system to treat children with solid tumours.